Price T Rowe Associates Inc Nevro Corp Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Nevro Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 100,371 shares of NVRO stock, worth $380,406. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,371

Previous 55,655 80.34%

Holding current value

$380,406

Previous $469,000 19.83%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $210,612 - $451,631	44,716 Added 80.34%	100,371 $562,000
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $84,686 - $144,584	10,639 Added 23.63%	55,655 $469,000
Q1 2024 May 15, 2024	BUY	$13.56 - $20.78 $94,974 - $145,543	7,004 Added 18.43%	45,016 $651,000
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $22,446 - $35,316	1,583 Added 4.35%	38,012 $819,000
Q3 2023 Nov 14, 2023	SELL	$18.22 - $25.85 $7.24 Million - $10.3 Million	-397,128 Reduced 91.6%	36,429 $701,000
Q2 2023 Aug 14, 2023	BUY	$22.62 - $39.32 $1.61 Million - $2.8 Million	71,228 Added 19.66%	433,557 $11 Million
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $2.47 Million - $3.37 Million	81,895 Added 29.2%	362,329 $13.1 Million
Q4 2022 Feb 14, 2023	SELL	$36.43 - $49.4 $367,906 - $498,890	-10,099 Reduced 3.48%	280,434 $11.1 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $29.6 Million - $38.7 Million	-728,899 Reduced 71.5%	290,533 $13.5 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $84.7 Million - $161 Million	-2,073,827 Reduced 67.04%	1,019,432 $44.7 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $45.8 Million - $70.4 Million	764,728 Added 32.84%	3,093,259 $224 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $190 Million - $284 Million	-2,343,234 Reduced 50.16%	2,328,531 $189 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $23,049 - $37,597	226 Added 0.0%	4,671,765 $544 Million
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $3.28 Million - $4.15 Million	-23,165 Reduced 0.49%	4,671,539 $774 Million
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $88.5 Million - $121 Million	666,384 Added 16.54%	4,694,704 $655 Million
Q4 2020 Feb 16, 2021	BUY	$138.17 - $184.34 $557 Million - $743 Million	4,028,320 New	4,028,320 $697 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $134M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Nevro Corp Transaction History